health New advanced leukemia drug leads to ‘impressive’ responses [ad_1] Revumenib, an Investigational Menin Inhibitor, Shows Encouraging Responses in Relapsed or Refractory Patients KMT2A-rearranged or MNP1-mutant acute… bynewsdeskMarch 20, 2023
health How blood cancer in some can progress as a disease: study [ad_1] A type of chronic leukemia, or cancer of the blood-forming tissues, can simmer for many years. For… bynewsdeskDecember 31, 2022
